UK cost agency backs melanoma drugs after price cuts

LONDON (Reuters) - Two new drugs for skin cancer have been recommended for use on Britain's state-run health service after the rival manufacturers - Roche and Bristol-Myers Squibb - agreed to cut their prices.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MX9xBNyhMA0/us-cancer-britain-nice-idUSBRE8A100220121102

certified phlebotomy technician california phlebotomy certification ny phlebotomist certification florida